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Background and objectives: Locus heterogeneity is well established in autosomal recessive primary
microcephaly (MCPH) and to date five loci have been mapped. However, the relative contributions of
these loci have not been assessed and genotype-phenotype correlations have not been investigated.
Design: A study population of 56 consanguineous families resident in or originating from northern
Pakistan was ascertained and assessed by the authors. A panel of microsatellite markers spanning
each of the MCPH loci was designed, against which the families were genotyped.
Results: The head circumference of the 131 affected subjects ranged from 4 to 14 SD below the mean,
but there was little intrafamilial variation among affecteds (± 1 SD). MCPH5 was the most prevalent,
with 24/56 families consistent with linkage; 2/56 families were compatible with linkage to MCPH1,
10/56 to MCPH2, 2/56 to MCPH3, none to MCPH4, and 18/56 did not segregate with any of the
loci.
Conclusions: MCPH5 is the most common locus in this population. On clinical grounds alone, the
phenotype of families linked to each MCPH locus could not be distinguished. We have also shown that
further MCPH loci await discovery with a number of families as yet unlinked.
Autosomal recessive primary microcephaly (MCPH) is arare human disorder in which the cerebral cortex isreduced in size and, as a consequence, the head circum-
ference is reduced.1 2 MCPH appears to arise through failure of
a normal developmental process and not regression or degen-
eration of established neuronal tissue. The consequence of the
disorder is mild to moderate mental retardation without other
neurological deficit.3 In this study, we defined MCPH as: a
congenital disorder in which an affected subject has micro-
cephaly of at least –4 SD (measured as occipitofrontal head
circumference and corrected for age and sex), and mild/
moderate mental retardation, in the absence of any general-
ised disorder of growth, abnormal neurological findings, fits,
or dysmorphic features and in which other syndromic, neuro-
logical, chromosomal,metabolic, andmaternal/environmental
diagnoses were sought and eliminated. When performed,
brain neuroimaging showed that the cerebral cortex is small
and symmetrical, other areas of the brain are of normal size,
and there are no structural anomalies or evidence of abnormal
neuronal migration.1
While MCPH apparently has a single clinical phenotype, it
exhibits genetic heterogeneity.2 We had previously used four of
the study families to identify MCPH gene loci using
autozygosity mapping4: MCPH1 (family 18), MCPH2 (family
27), MCPH3 (family 1), and MCPH5 (family 38).5–9 A further
locus, MCPH4, was found by Jamieson et al10 in a consanguin-
eous Turkish family.10 To date, no MCPH gene has been
published (see note added in proof).
The aims of this study were threefold: firstly, to document
the phenotype of a large number of subjects affected with
MCPH, secondly, to determine the relative frequency of each
of the five MCPH loci within one ethnic population, and,
thirdly, to use the genotype data to seek interlocus and
intralocus phenotype differences.
METHODS
Fifty-six consanguineous families of northern Pakistani
origin containing one or more members with MCPH were
ascertained. Families were referred to the authors from two
sources: from paediatricians in Yorkshire, UK (serving a large
northern Pakistani population centred upon Bradford) and
from paediatricians and Special Schools in Rawalpindi,
Islamabad, and Lahore in Pakistan (which is the geographical
origin of the majority of Asians in Yorkshire). One of the
authors obtained a medical history and family pedigree and
examined all potentially affected subjects. Ethical Committee
consent for this study has been given.
Family members gave blood samples from which DNA was
obtained by standard methods. For each MCPH locus, a panel
of microsatellite markers was devised (table 1). Each of the 56
families was genotyped against the five known MCPH loci
using these panels. As all of the families are consanguineous,
identity by descent could be sought and used to assess
evidence of linkage to a particular locus.11
RESULTS
In the 56 study families, there were 131 MCPH affected mem-
bers with a male to female ratio of 70:61. Of these families,
20/56 contained affected subjects in more than one sibship,
22/56 were a single sibship with multiple affected subjects,
and in 14/56 a single offspring was affected. All affected sub-
jects were microcephalic at birth with a head circumference
between –4 and –14 SD (fig 1). In fifteen of them, the degree
of microcephaly at birth could be compared to that at 5-10
years of age and no difference was seen, implying that this is
not a progressive condition. There was no sex difference in the
degree of microcephaly or the gross cognitive ability. Within
multiply affected families, head circumferences usually varied
only by ± 1 SD. Where there was a greater variation in head
circumference, this was confined to older affected members
(>30 years of age) of the family, who had a reduced relative
head circumference compared to their younger affected family
relatives. All study subjects enjoyed good health, comparable
to their unaffected family members. All had normal early
motor milestones but some had delay in speech (in acquisition
of vocabulary and grammar but without dysarthria), none had
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severe or profound mental retardation, and none had epilepsy.
Most were physically able and the majority were personable,
biddable, and trainable in life skills. Some had “sloping
foreheads”, but within a family this was an inconsistent
feature.1 All parents were of normal physical and mental abil-
ity and none had microcephaly.
The genotype results are reported in table 2: 2/56 families
were consistent with linkage toMCPH1 (4%), 10/56 toMCPH2
(18%), 2/56 to MCPH3 (4%), none to MCPH4, and 24/56 to
MCPH5 (43%). In two multi-affected families likely to be
linked to MCPH5, a subject was homozygous for a smaller
region while carrying the larger family haplotype. We have
used these results to refine this locus further. One singleton
was homozygous for all markers for both the MCPH2 and
MCPH3 loci. In 18/56 families (32%), there was no definite
evidence of linkage to one of the five known loci. However,
three of these families had affected subjects with a concordant
haplotype for MCPH3markers (that is, the same heterozygous
allele results for all polymorphic microsatellite markers
assessed) suggesting the possibility of linkage to a smaller
homozygous region contained within this haplotype.
Bearing in mind the possibility of a child of first cousin par-
ents carrying a homozygous region by descent rather than as
the disease allele is 1 in 16, whereas in multi-affected
pedigrees this chance decreases, and that clinical misdiagnosis
must always be considered in a “diagnosis of exclusion” such
as MCPH, and such phenocopies are more likely in single
affected families,3 then, excluding singletons from the analy-
sis, 2/42 families are compatible with linkage to MCPH1 (5%),
6/42 to MCPH2 (14%), 1/42 to MCPH3 (2%), none to MCPH4,
19/42 to MCPH5 (45%), and 14/42 families (33%) did not seg-
regate with any of the loci. This suggests that inclusion of sin-
gletons in our analysis was not a major cause of error. All indi-
vidual head circumferences and the mean for each family
were analysed against the MCPH loci genotype data and there
was no discernable difference (table 3).
DISCUSSION
Given the large number of disorders that cause “mental retar-
dation with microcephaly”, it is important from a clinical per-
spective to attempt to split such a broad phenotypic category
into more discrete entities. To this end we report a large cohort
of subjects in whom we have made a clinical diagnosis of
autosomal recessive primary microcephaly (MCPH). Support-
ing the definition of MCPH as a clinical neurodevelopmental
disorder is both the numbers of cases we have amassed and
the fact that genetic linkages for MCPH loci have been identi-
fied. We suggest that autosomal recessive primary micro-
cephaly may be a more exact and useful term than others in
use, for example, “true microcephaly”, “recessive micro-
cephaly”, or “microcephaly vera”.3 Certainly, in our study
population the “true microcephaly” phenotype with the slop-
ing forehead was not a consistent finding in subjects affected
with MCPH. It has also been suggested that carriers of MCPH
have diminished intelligence as a heterozygote effect,15 though
we found no evidence of this.
In conclusion, we suggest that MCPH can be defined as a
clinical entity. It was considered that it would exhibit genetic
heterogeneity16 17 and this has now been confirmed, with five
MCPH loci reported to date.2 We have established the relative
incidence of each locus in the northern Pakistani population
and that MCPH5 is the most common in this ethnic group.
Interestingly, none of our northern Pakistani families link to
the MCPH4 locus,10 which was identified in a Turkish popula-
tion. Following genotyping of the study families, we were
unable to differentiate clinically between families linked to
Table 1 MCPH locus information
Primary
microcephaly
locus
Chromosomal
location
Size of locus
(genetic)
Markers used (pter flanking - within locus - qter
flanking)
MCPH15 8p23.1 13 cM D8S1824-
D8S1798/D8S1819/D8S1825/D8S552/D89S1731
-D8S261
MCPH26 19q13 5 cM D19S569-
D19S896/D19S897/D19S200
-D19S223
MCPH37 9q34 25 cM D9S195-
D9S1682/D9S1821/D9S290
-D9S159
MCPH410 15q14 19 cM D15S118-
D15S1012/D15S994/D15S990
-D15S117
MCPH58 9 1q31.3 5 cM GATA135F02-
D1S1726/D1S1723
-D1S1647
Figure 1 Head circumference measurements of all affected subjects
shown as standard deviation from norms by age and sex. Each point
represents one or more persons with a diagnosis of autosomal
recessive primary microcephaly. The head circumference as a
standard deviation from the age and sex norm is shown on the y
axis.12–14 The age of the subjects is shown in years on the x axis. The
sex is shown as a circle for a male and a square for a female.
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the five MCPH loci. We have also shown that further MCPH
loci await discovery with a number of families as yet unlinked.
It seems likely that determination of theMCPH genes will give
valuable insights into normal brain development (and
possibly the evolutionary process of encephalisation, where
the surface area of the cerebral cortex has tripled in size from
primates to man18), as well as providing new therapeutic
options for affected families.
NOTE ADDED IN PROOF
The MCPH1 gene has now been identified.19
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Table 2 Study family data summary
Pedigree No*
Mean head
circum-
ference†
No of
affecteds in
each sibship‡
Loci that were
homozygous or
concordant for each
pedigree§
1 −7 2+2 MCPH3
2 −5 1+1 MCPH5
3 −4 4 None
4 −4 2 MCPH5
5 −11 1 MCPH5
6 −6 2 MCPH2
7 −4 1 MCPH3
8 −7 1 MCPH2
9 −6 1 MCPH5
10 −4 2+1 MCPH2
11 −12 1 MCPH2
12 −11 3 MCPH5
13 −6 2 None
14 −4 2+1 None
15 −6 2 MCPH5
16 −7 2+1 MCPH5
17 −4.5 2 None
18 −7 2+2+1 MCPH1
19 −7.5 2 MCPH5
20 −8.5 2 MCPH5
21 −8 3 MCPH5
22 −8 1+1 MCPH5
23 −6 3 Concordant for
MCPH3
24 −10 2 MCPH1
25 −6 2+1 MCPH2
26 −5 1 MCPH5
27 −6.5 2+2+1+1 MCPH2
28 −7.5 1+1 None
29 −10 1 MCPH5
30 −9 1+1+2+3+1 MCPH2
31 −4 3+1+1 None
32 −5 2 Concordant for
MCPH4
33 −10 2+1 MCPH5
34 −6 2 Concordant for
MCPH3
35 −7.5 2 MCPH2
36 −9 2+2 None
37 −5 3+1+1 None
38 −9 1+1+1 MCPH5
39 −8 2 None
40 −4.5 1+1 None
41 −9.5 2 MCPH5
42 −10 1 MCPH5
43 −6 2 Concordant for
MCPH3
44 −6 3+1 MCPH5
45 −5 1 None
46 −9 2 MCPH5
47 −6 3 MCPH5
48 −6 2 MCPH5
49 −5 1 MCPH2 and MCPH3
50 −6 1 MCPH2
51 −4 1 None
52 −5 1 None
53 −4 1 MCPH2
54 −6 2 MCPH5
55 −9 2+1 MCPH5
56 −9 1+5+4+2 MCPH5
*The families are numbered sequentially based upon their
chronological ascertainment into the study.
†The mean head circumference for the affected subjects in each
family is given as a standard deviation from the age and sex norm.
‡The number of affected subjects is given by sibships, for example,
two sibs and a cousin would be represented as “2+1”, and only
includes those assessed as affected by the authors and in whom
genotyping was performed.
§The MCPH locus to which each family is most likely to be linked was
derived from the genotyping results as follows: if all affected
member(s) of a family had the same homozygous haplotype for a
MCPH locus the family was designated linked; if the affected
members had different heterozygous marker results or different
homozygous haplotypes the family was regarded as not linked; and if
all affected subjects had identical concordant, but heterozygous,
haplotypes the family were not regarded as proven linked to the locus
but noted as concordant.
Table 3 Mean head circumference measurement for
families linked to each MCPH locus. The mean head
circumference is corrected for age and sex. Only
families with >1 affected member are included to
reduce the effect of incorrect clinical diagnosis.
MCPH4 is not shown as none of the study families
were linked. “Unknown MCPH” includes all families
not linked to a known MCPH locus
MCPH locus
No of multi-affected
families
Mean head
circumference
(SD (range))
MCPH1 2 −8.5 (−7 to −10)
MCPH2 6 −6.5 (−4 to −9)
MCPH3 1 −7
MCPH5 19 −7.5 (−4 to −11)
Unknown MCPH 14 −5.5 (−4 to −9)
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Variant of endothelial nitric oxide synthase gene determines severity of
atherosclerosis
Acommon variant of an enzyme which produces nitric oxide in endothelial cells may in futurebecome a genetic marker for susceptibility to atherosclerosis.
Researchers in Italy have shown for the first time that the polymorphic Glu→Asp variant of endothe-
lial nitric oxide synthase (eNOS) is linked to the extent and severity of coronary artery disease (CAD).
Of the three possible eNOS genotypes, the Asp/Asp homozygous genotype had a higher frequency in
patients with CAD than controls (15.9% v 6.1%) whereas the Glu/Glu and Glu/Asp genotypes did not. The
likelihood of having the Asp/Asp genotype and CAD was 2.9 (95% confidence interval 1.2 to 6.8) when
compared with the other genotypes combined. Multiple regression showed that Asp/Asp was an
independent risk factor for CAD. This genotype had no relation with other known risk factors but was
significantly associated with number of narrowed vessels (mean (SEM) 2.3 (0.1) for Asp/Asp v 1.9 (0.1)
for Glu/Glu, and 1.8 (0.1) for Glu/Asp, respectively) and higher Duke score, denoting severity of CAD
(mean (SEM) 56.1(3.1), 46.7(2.0), and 46.1(1.9), respectively).
The study population included 201 patients with CAD, who had more than 50% narrowing of more
than one vessel on angiography, and 114 controls with no CAD awaiting valve replacements. Amplifica-
tion of DNA by polymerase chain reaction and restriction fragment length polymorphism (RFLP) analy-
sis were used to ascertain eNOS genotype.
Nitric oxide in endothelium inhibits many pathogenetic mechanisms in atherosclerosis, and the
Glu298→Asp polymorphism has previously been reported in CAD and myocardial infarction.
m Heart 2002;87:525–528.
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